Difference between revisions of "Key molecular pathways in ALS"
From MyWiki
Line 1: | Line 1: | ||
{̺{tip|For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac}} | {̺{tip|For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac}} | ||
− | + | ||
+ | {̺| class="wikitable" | ||
! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits | ! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits | ||
|- | |- |
Revision as of 09:39, 28 February 2018
{̺{tip|For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac}}
{̺| class="wikitable" ! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits |- | NF-kappaB || Inflammatory |- | TNF-alpha |- | caspase-3 |- | AMPK-α1 |- | IL-10 |- | SARM1 |- | PKC |- | VEGF
|}